Skip to Content

CytoSorbents Corp CTSO

Morningstar Rating
$0.95 −0.01 (1.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CTSO is trading at a 49% discount.
Price
$0.97
Fair Value
$2.33
Uncertainty
Extreme
1-Star Price
$9.60
5-Star Price
$7.96
Economic Moat
Vtzv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CTSO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.96
Day Range
$0.930.99
52-Week Range
$0.864.29
Bid/Ask
$0.93 / $0.99
Market Cap
$49.50 Mil
Volume/Avg
51,768 / 394,046

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.33
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
198

Comparables

Valuation

Metric
CTSO
EMBC
ATEC
Price/Earnings (Normalized)
4.49
Price/Book Value
2.2823.92
Price/Sales
1.330.733.37
Price/Cash Flow
7.01
Price/Earnings
CTSO
EMBC
ATEC

Financial Strength

Metric
CTSO
EMBC
ATEC
Quick Ratio
1.211.551.86
Current Ratio
1.612.202.86
Interest Coverage
−471.541.59−10.23
Quick Ratio
CTSO
EMBC
ATEC

Profitability

Metric
CTSO
EMBC
ATEC
Return on Assets (Normalized)
−40.34%12.52%−9.88%
Return on Equity (Normalized)
−78.15%
Return on Invested Capital (Normalized)
−49.09%30.00%−9.93%
Return on Assets
CTSO
EMBC
ATEC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ABT
Abbott LaboratoriesQzbjn$205.8 Bil
SYK
Stryker CorpYkgr$134.3 Bil
MDT
Medtronic PLCNkqd$111.0 Bil
BSX
Boston Scientific CorpRnvzt$98.5 Bil
EW
Edwards Lifesciences CorpSbglht$51.2 Bil
DXCM
DexCom IncZqbh$46.9 Bil
ZBH
Zimmer Biomet Holdings IncXrzm$25.4 Bil
ALGN
Align Technology IncZbkxjn$23.0 Bil
PHG
Koninklijke Philips NV ADRFqhlx$18.4 Bil
PODD
Insulet CorpFqlwvjg$11.8 Bil

Sponsor Center